2011
DOI: 10.1007/s12032-010-9817-4
|View full text |Cite
|
Sign up to set email alerts
|

The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer

Abstract: We investigated the correlation of vascular endothelial growth factor C, matrix metalloproteinase-2, E-cadherin to explore mechanisms of vascular endothelial growth factor C in the metastasis of ovarian cancer and the relationship of prognosis. We applied immunohistochemistry to investigate the expression of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in ovarian tissues of 227 patients. We adopted Pearson chi-square test, Spearman correlation coefficient, univariate analysis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 20 publications
1
27
0
2
Order By: Relevance
“…28 Of the 73 esophageal squamous cell carcinomas patients studied by Liu et al, 29 the median overall survival of 39 patients who had positive staining for tumor cell VEGF-C and 34 patients who had negative staining were 10.4 and 28.5 months, Fig. 3 Disease-specific overall survival (a) and disease-free survival (b) in risk group Fig.…”
Section: Roles Of Vegf-c and Smad4 In The Prognosis Of Colon Cancermentioning
confidence: 95%
“…28 Of the 73 esophageal squamous cell carcinomas patients studied by Liu et al, 29 the median overall survival of 39 patients who had positive staining for tumor cell VEGF-C and 34 patients who had negative staining were 10.4 and 28.5 months, Fig. 3 Disease-specific overall survival (a) and disease-free survival (b) in risk group Fig.…”
Section: Roles Of Vegf-c and Smad4 In The Prognosis Of Colon Cancermentioning
confidence: 95%
“…At last, 30 studies Lee et al, 2000;Lengyel et al, 2001;Li et al, 2003;Ozalp et al, 2003;Määttä et al, 2004;Sood et al, 2004;Wang et al, 2004;Ge et al, 2005;Wang et al, 2005;Kamat et al, 2006;Shen et al, 2006;Zhang et al, 2006;Sillanpää et al, 2007;Tian et al, 2007;Wu et al, 2007;Xing et al, 2007;Zhang et al, 2007;Li et al, 2008;Sun et al, 2008;Yan et al, 2008;Alshenawy et al, 2010;Zeng et al, 2010;Guo et al, 2011;Hu et al, 2011;Qin et al, 2011;Wang et al, 2011;Zhang et al, 2011;Hu et al, 2012;Jean et al, 2012) were included in the meta-analysis. The characteristics of these 30 included studies for the meta-analysis are summarized (Table 1).…”
Section: Figure 2 Forest Plot Of Hr With a Random-effects Model For mentioning
confidence: 99%
“…Majority of population in meta-analysis were in FIGO stages III and IV, therefore the above stated conclusion may be more suitable for advanced ovarian cancer [27]. Negative results have also published making this field more complicated [31,53,54]. Potential limitations of our study were a relative small number of patients with ovarian cancer and short median follow-up.…”
Section: Discussionmentioning
confidence: 83%